Trevi Therapeutics, Inc. (TRVI)
↓ Download CSVKey ratios (FY2025)
-23.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$49.33M | -$51.52M | -$33.92M | -$29.91M | -$32.48M | -$32.49M | -$26.64M | -$18.41M | — |
| Net Income | -$42.76M | -$47.91M | -$29.07M | -$29.15M | -$33.94M | -$32.76M | -$26.05M | -$20.55M | — |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | — | — | — | — |
| Total Assets | $193.44M | $110.90M | $89.40M | $123.02M | $38.48M | $47.13M | $60.00M | $10.53M | — |
| Total Liabilities | $10.20M | $11.26M | $6.86M | $15.56M | $21.40M | $19.85M | — | — | — |
| Shareholders' Equity | $183.24M | $99.64M | $82.55M | $107.46M | $17.07M | $27.28M | $54.55M | -$109.49M | -$84.43M |
| Cash & Equivalents | $18.91M | $34.10M | $32.40M | $12.59M | $36.83M | $45.00M | $57.31M | $7.20M | — |
| Operating Cash Flow | -$42.09M | -$38.26M | -$31.71M | -$28.18M | -$28.95M | -$29.00M | -$23.09M | -$18.29M | — |
| Capital Expenditures | $12.0K | $35.0K | $137.0K | $159.0K | — | $32.0K | $9.0K | $158.0K | — |
| Shares Outstanding | 128.31M | 93.60M | 68.28M | 59.94M | 28.51M | 18.55M | 17.83M | 438.6K | — |